IDDF2020-ABS-0070 Proteomic Analysis of Colorectal Cancer with BRAFV600E Mutation

Biting Zhou,Kailun Xu,Yingkuan Shao,Xi Zheng,Shu Zheng

DOI: https://doi.org/10.1136/gutjnl-2020-iddf.59

2020-01-01

Abstract:Background Proteomics provides new insights on tumorigenesis and progression of colorectal cancer (CRC) dependent of genomics and transcriptomics. BRAFV600E mutation is an unfavorable prognosis biomarker, occurring in about 5–20% CRC. In this study, we aimed to figure out the molecular characteristics in CRC with BRAFV600E mutation in proteomics. Methods Based on a novel approach combining pressure cycling technology with the data-independent acquisition of mass spectrometry, thousands of peptides were obtained from formalin-fixed paraffin-embedded tumor tissue samples from 249 patients with colon cancer during 2009–2012 and then were processed through OpenSWATH to get the protein matrix. Differentially expressed proteins were analyzed by t-test (p-value < 0.05, fold-change > 1.5/<2/3). BRAFV600E mutation status was tested by amplification-refractory-mutation-system-based PCR assays. Biological function and pathway enrichment analysis were performed by STRING. Results 27 patients were proved BRAFV600E mutation, indicating 10.8% occurrence rate in our CRC cohort. 276 differentially expressed proteins were obtained, including 243 upregulated and 33 downregulated in BRAFV600E mutation versus matched wild type (figure 1). The most significant biological processes for overexpressed proteins are interferon-gamma-mediated signaling pathway and antigen processing and presentation of exogenous peptide antigen, while for downregulated proteins is ncRNA metabolic process. In BRAFV600E mutated samples, 151 differentially expressed proteins were obtained, including 131 downregulated and 20 upregulated from patients’ overall survival less than 5 years versus exceeding 5 years (figure 2). The overrepresented biological process and molecular functions are leukocyte mediated immunity and SHG alpha-glucan phosphorylase activity for overexpressed proteins, while ribosome biogenesis and RNA binding for downregulated proteins. Conclusions Based on the general and primary proteomic analysis, we found that BRAFV600E mutated CRC exhibited immune-related characteristics, and the poor prognosis might relate to the abnormal metabolic process. Relevant mechanisms and pathways will be studied in further research.